(Overview) The Providence/Boston Center for AIDS Research (CFAR) is composed of two academic institutions, Brown University and Boston University, their affiliated hospitals, Lifespan and Boston Medical Center (BMC), and the RI Department of Health, MA Department of Public Health, local community organizations, and international sites. The mission of the Providence/Boston CFAR is to promote the NIH HIV priority research agenda. We are devoted to the pursuit of translational research to reduce the burden of HIV infection worldwide, with special focus on substance users, women, MSM, justice-involved persons, and at-risk youth. To achieve this goal, we are committed to fostering emerging HIV investigators both domestically and within resource-limited settings. The CFAR consists of 6 Cores (Administrative, Developmental, BioBehavioral Sciences, Biostatistics, Basic and Translational Sciences, Substance Use Research), and one HIV/TB Scientific Working Group. We have a strong, dynamic group of HIV researchers from our long history, and expect continued growth from the addition of Boston University Medical Campus (BUMC) investigators. Our goal is to decrease the HIV epidemic by advancing research in prevention, treatment and its cascade, and the care of co- morbidities among the most afflicted and vulnerable populations. The Cores are strategically formed to support areas of strength among the Providence/Boston CFAR investigators. Our investigators have innovative approaches in biomedical prevention, treatment modalities, and cutting-edge research on substance use, leveraging our unique position of having an alcohol and HIV center within each institution. Our HIV in women's program has a long history of defining the natural history of HIV in women, pathogenesis, and prevention, including microbicide research. The partnership also brings research strength in economic analysis, cost- effectiveness, computational biology, and HIV/TB.

Public Health Relevance

(OVERVIEW) The Providence/Boston CFAR, a collaboration between Brown University/Lifespan and Boston University and Boston Medical Center (BUMC), has the leadership, infrastructure, and a wide range of HIV/AIDS Core services for our research community to promote the NIH HIV priority research agenda. Our CFAR is devoted to the pursuit of translational research to reduce the burden of HIV infection worldwide, with special focus on substance users, women, MSM, justice-involved persons, and at-risk youth. To achieve this goal, we are committed to fostering emerging HIV investigators both domestically and within resource-limited settings.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI042853-22
Application #
9953978
Study Section
Special Emphasis Panel (ZAI1)
Program Officer
Wong, Elaine Wai-Ken
Project Start
1998-09-01
Project End
2023-06-30
Budget Start
2020-07-01
Budget End
2021-06-30
Support Year
22
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Miriam Hospital
Department
Type
DUNS #
063902704
City
Providence
State
RI
Country
United States
Zip Code
02906
Skeer, Margie R; Ladin, Keren; Wilkins, Lindsay E et al. (2018) 'Hep C's like the common cold': understanding barriers along the HCV care continuum among young people who inject drugs. Drug Alcohol Depend 190:246-254
Ma, Y; Horsburgh, C R; White, L F et al. (2018) Quantifying TB transmission: a systematic review of reproduction number and serial interval estimates for tuberculosis. Epidemiol Infect 146:1478-1494
Wurcel, Alysse G; Burke, Deirdre; Skeer, Margie et al. (2018) Sex work, injection drug use, and abscesses: Associations in women, but not men. Drug Alcohol Depend 185:293-297
Dompreh, Albert; Tang, Xiaoli; Zhou, Jianlin et al. (2018) Effect of Genetic Variation of NAT2 on Isoniazid and SLCO1B1 and CES2 on Rifampin Pharmacokinetics in Ghanaian Children with Tuberculosis. Antimicrob Agents Chemother 62:
Schackman, Bruce R; Gutkind, Sarah; Morgan, Jake R et al. (2018) Cost-effectiveness of hepatitis C screening and treatment linkage intervention in US methadone maintenance treatment programs. Drug Alcohol Depend 185:411-420
Adams, Joƫlla W; Bryant, Kendall J; Edelman, Jennifer E et al. (2018) Association of Cannabis, Stimulant, and Alcohol use with Mortality Prognosis Among HIV-Infected Men. AIDS Behav 22:1341-1351
Krieger, Maxwell S; Yedinak, Jesse L; Buxton, Jane A et al. (2018) High willingness to use rapid fentanyl test strips among young adults who use drugs. Harm Reduct J 15:7
Bazazi, Alexander R; Vijay, Aishwarya; Crawford, Forrest W et al. (2018) HIV Testing and awareness of HIV status among people who inject drugs in greater Kuala Lumpur, Malaysia. AIDS Care 30:59-64
van den Berg, Jacob J; Javanbakht, Marjan; Gorbach, Pamina M et al. (2018) Partner Notification for Youth Living With HIV in 14 Cities in the United States. J Acquir Immune Defic Syndr 77:46-52
Hu, Liangyuan; Hogan, Joseph W; Mwangi, Ann W et al. (2018) Modeling the causal effect of treatment initiation time on survival: Application to HIV/TB co-infection. Biometrics 74:703-713

Showing the most recent 10 out of 806 publications